Search filters

List of works by Do-Youn Oh

A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions

scientific article

A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer

scientific article

A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker

scientific article published on May 1, 2008

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

scientific article

A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer

scientific article

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

scientific article

A-kinase anchoring protein 12 regulates the completion of cytokinesis

scientific article

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

scientific article

ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy

scientific article

Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience

scientific article published in April 2012

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study

scientific article published on 27 September 2009

Age <40Years is an independent prognostic factor predicting inferior overall survival in patients treated with breast conservative therapy

scientific article published on 06 December 2010

Aggressiveness of cancer-care near the end-of-life in Korea

scientific article published on 14 April 2008

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer

scientific article published on February 22, 2011

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

scientific article published on March 1, 2012

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

scientific article published on March 28, 2011

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

scientific article published on 3 May 2011

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer

scientific article published on November 9, 2012

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.

scientific article published on 11 March 2011

Ataxia‐telangiectasia‐mutated protein expression with microsatellite instability in gastric cancer as prognostic marker

scientific article published on September 17, 2013

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

scientific article

Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data

scientific article published on December 31, 2012

CD24 expression predicts distant metastasis in extrahepatic bile duct cancer

scientific article published on March 2013

CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience

scientific article

Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors

scientific article published on 22 January 2008

Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung Cancer

scientific article published on 31 December 2013

Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung)

scientific article published on 01 December 2012

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

scientific article published on 22 September 2011

Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy

scientific article published on 01 April 2011

Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients

scientific article published on 7 September 2006

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.

scientific article published on 12 September 2008

Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer

scientific article published on 26 March 2013

Clinicopathologic Characteristics of Patients With Stage III/IV (M0) Advanced Gastric Cancer, According to HER2 Status Assessed by Immunohistochemistry and Fluorescence In Situ Hybridization

scientific article published on June 1, 2011

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer

scientific article published on May 19, 2011

Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study

scientific article published on 01 September 2010

Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.

scientific article published on December 2010

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

scientific article published on 15 September 2009

Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells

scientific article

Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX

scientific article published on 26 August 2020

Comparisons of Clinical Outcomes between Weekday-Only and Full-Time, 24-Hour/7-Day Coverage Hospitalist Systems

scientific article published on 11 May 2020

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

scientific article published on 16 October 2015

Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer

scientific article published in May 2011

Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer

scientific article published on July 27, 2012

Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis

scientific article published on 19 December 2017

DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells

scientific article

DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription

scientific article

DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.

scientific article

Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection

scientific article

Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer

scientific article published on April 30, 2013

Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab

scientific article published on March 15, 2011

Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression?

scientific article published in November 2007

Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer

scientific article published on 10 July 2012

Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy?

scientific article published on 27 October 2008

Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer

scientific article published on July 1, 2011

Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells

scientific article

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

scientific article published on 26 November 2007

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy

scientific article published on October 20, 2011

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea

scientific article

Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitors

scientific article published on 31 March 2013

Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting

scientific article

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.

scientific article

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.

scientific article published on 23 November 2009

Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer

scientific article published on June 2006

Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma

scientific article

Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expression

scientific article published on 03 July 2012

Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer

scientific article published on December 1, 2011

Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer

scientific article published on 01 March 2010

Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer

scientific article published on 30 June 2008

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

scientific article

Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers

scientific article

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer

scientific article published on May 15, 2013

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody

scientific article published on March 16, 2012

High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer

scientific article published on October 9, 2010

Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor

scientific article published on 04 November 2019

Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer

scientific article published in August 2014

Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors

scientific article

Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study

scientific article published on November 24, 2010

Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer

scientific article

Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial

scientific article published on 25 June 2020

Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer

scientific article published on 01 May 2007

Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer

scientific article

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival

scientific article published on December 25, 2012

Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?

scientific article published on 4 December 2009

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach

scientific article published on April 2010

KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.

scientific article published on 3 June 2014

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

scientific article published on March 2, 2011

Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer

scientific article published on 14 February 2009

Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy

scientific article published on 17 October 2012

Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.

scientific article

Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer

scientific article published on 21 June 2016

Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity

scientific article published on 3 November 2009

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

scientific article published on 29 October 2012

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

scientific article

Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment

scientific article

Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study

scientific article published on 28 November 2015

NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

scientific article published on December 8, 2011

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

scientific article published on 30 June 2011

Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.

scientific article

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells

scientific article published on February 10, 2013

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

scientific article

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles

scientific article published on 20 December 2016

Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer

scientific article published on June 29, 2012

Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells

scientific article

Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

scientific article

Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer

scientific article published on January 13, 2013

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

scientific article

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer

scientific article

Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02

scientific article published on April 8, 2013

Postoperative chemoradiotherapy in high risk locally advanced gastric cancer

scientific article published on 31 December 2012

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

scientific article published on 14 February 2005

Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy

scientific article published on 07 February 2012

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

scientific article published on 22 January 2019

Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy

scientific article published on 01 February 2010

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy

scientific article published in June 2010

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses

scientific article published on 21 July 2016

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

scientific article

Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study

scientific article published on September 25, 2010

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

scientific article published on 14 October 2015

Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients

scientific article published on 26 April 2019

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

scientific article

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma

scientific article published on 01 May 2012

Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy

scientific article

Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma

scientific article

RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase

scientific article published on August 19, 2010

RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

scientific article published on March 19, 2013

Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer

scientific article

Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer

scientific article published on October 2005

Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.

scientific article published on 23 April 2009

Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience

scientific article published on 01 December 2012

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

scientific article published on 15 September 2013

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

scientific article published on 24 January 2009

Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer

scientific article published on January 20, 2012

TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells

scientific article

TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials

scientific article published on 13 October 2016

Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing

scientific article published on 21 May 2013

The Impact of Primary Tumor Resection on the Survival of Patients with Stage IV Breast Cancer

The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use

scientific article published on September 5, 2012

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

scientific article

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

scientific article published on 6 September 2008

The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy.

scientific article published on 8 December 2013

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer

scientific article published on 5 December 2013

The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines

scientific article published on December 25, 2011

The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen

scientific article published on 01 April 2012

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer

scientific article published on 11 August 2009

The role of PET/CT in detection of gastric cancer recurrence

scientific article

The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma

scientific article published on 05 February 2011

Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

scientific article published on January 2008

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

scientific article

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation

scientific article published on October 7, 2012

VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib

scientific article published on September 1, 2011

Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy

scientific article published on 24 September 2009

Weight changes after adjuvant treatment in Korean women with early breast cancer

scientific article published on 26 March 2008

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

scientific article published on 8 March 2015

Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression

scientific article